NLRP3 inflammasome-dependent caspase-1 activation is an important pathway related to IL-1β release [39] and has been implicated in the pathophysiology of neurological diseases, including Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, and epilepsy [40–42]. This evidence concerns the gene CASP1 and Alzheimer disease.